Tigecycline reduces tumorigenesis in colorectal cancer via inhibition of cell proliferation and modulation of immune response Ruiz Malagón, Antonio Jesús Hidalgo García, Laura Rodríguez Sojo, María Jesús Molina Tijeras, José Alberto Díez Echave, Patricia Vezza, Teresa Rodríguez Cabezas, María Elena Rodríguez Nogales, Alba Gálvez Peralta, Julio Juan Colitis-associated colorectal cancer Tigecycline β-catenin Cytotoxic T lymphocytes Microbiota 2023-06-29T10:08:11Z 2023-06-29T10:08:11Z 2023-04-27 journal article A.J. Ruiz-Malagón et al. Tigecycline reduces tumorigenesis in colorectal cancer via inhibition of cell proliferation and modulation of immune response. Biomedicine & Pharmacotherapy 163 (2023) 114760[https://doi.org/10.1016/j.biopha.2023.114760] https://hdl.handle.net/10481/82946 10.1016/j.biopha.2023.114760 eng http://creativecommons.org/licenses/by-nc-nd/4.0/ open access Attribution-NonCommercial-NoDerivatives 4.0 Internacional Elsevier